Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Bile acids are amphiphilic molecules with 24 carbon atoms, consisting of a hydrophobic and a rigid steroid nucleus, which they are attached a hydrophilic hydroxyl groups and a flexible acidic aliphatic side chain . The steroidal core of bile acids constitutes a saturated cyclopentanoperhydrophenanthrene skeleton, consisting of three six-membered (A, B and C) and one five-membered ring (D). Primary bile acids are produced in the hepatocytes, while secondary bile acids are formed by modifying of primary bile acids in the intestinal lumen, i.e. by the reactions of 7alfa−dehydroxylation and deconjugation of cholic and chenodeoxycholic acid. The most important secondary bile acids are deoxycholic and lithocholic acid. Their effects, bile acids realize through nuclear FXR receptors and membrane TGR5 receptors. It has been found that bile acids are also associated with other receptor-vitamin D receptor (VDR), which the most significant ligand is calcitriol, as well as for the pregnane X receptor (PXR) and potentially for the constitutive androstane receptor (CAR), whose ligands are numerous, structurally different xenobiotics, which are associated with greater affinity for bile acids. Bile acids as absorption promoters have the potential to aid intestinal, buccal, transdermal, ocular, nasal, rectal and pulmonary absorption. Bile acids as therapeutic agents (drugs) have the potential to produce beneficial effects in sexually transmitted diseases, primary biliary cirrhosis, primary sclerosing cholangitis, gallstones, digestive tract diseases, cystic fibrosis and cancer. Ursodeoxycholic acid possesses cholesthetic and antiprotective properties and it is used in the treatment of hepatobiliary symptoms of cystic fibrosis. The ursodeoxocholic acid normalizes the function of the liver, tests and prevents the progression of fibrosis. Bile acids achieve most of their effects by modulating gene expression through nuclear receptors, as a transcription factor. In this paper, the different pathways of bile acid biosynthesis are explained as well as chemical modifications and synthesis of different keto derivatives of bile acids. Also, the effects of bile acids in digestion as nutrients, their role as drugs, and in particular the emphasis on the hypoglycemic properties of 7alfa, 12alfa−dihydroxy−12−keto−5beta−cholanic acid in the treatment of diabetes mellitus were examined in detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069 · cited 2×
“The 3β-hydroxy–1(5)-C27-oxidoreductase (HSD3B7) converts 7α-hydroxycholesterol to the 3–oxo–14-form after which 14-3–oxosteroid−5β-reductase (AKR1D1) reduces the 14 double bond leading to the formation of 5β-hydrogen configuration (Russell, 2003).”
BackgroundBile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594
Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.005 · Cited by 576
Hypoglycemia in Type 2 Diabetes
Zammitt, N. N., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2948 · Cited by 435
Fifty years of advances in bile acid synthesis and metabolism
Russell, D. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800026-jlr200 · Cited by 358
Epidemiology and natural history of primary biliary cirrhosis in a U.S. community
Kim, W. R., Lindor, K. D., Locke, G. R., Therneau, T. M., Homburger, H. A., Batts, K. P., Yawn, B. P., Petz, J. L., Melton, L. J., & Dickson, E. R. (2000) · Gastroenterology · doi:10.1053/gast.2000.20197 · Cited by 349
Cited by
Suriano, F., Vieira-Silva, S., Falony, G., Roumain, M., Paquot, A., Pelicaen, R., Régnier, M., Delzenne, N. M., Raes, J., Muccioli, G. G., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01097-8 · Cited by 263
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208
The biosynthesis, signaling, and neurological functions of bile acids
Kiriyama, Y., & Nochi, H. (2019) · Biomolecules · doi:10.3390/biom9060232 · Cited by 204
“Moreover, UDCA, which is approved by the US Food and Drug Administration for the treatment of primary biliary cirrhosis [192], can enter the cerebrospinal fluid after oral administration [193].”
BackgroundMeier, K. H. U., Trouillon, J., Li, H., Lang, M., Fuhrer, T., Zamboni, N., Sunagawa, S., Macpherson, A. J., & Sauer, U. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00802-1 · Cited by 48
Zhang, Q., Fan, X.-Y., Guo, W.-L., Cao, Y.-J., Lin, Y.-C., Cheng, W.-J., Chen, L.-J., Rao, P.-F., Ni, L., & Lv, X.-C. (2020) · Food & Function · doi:10.1039/d0fo00065e · Cited by 42
Metadata
- Authors
- Šarenac, T. M., & Mikov, M.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-25
- Volume
- 9
- Pages
- 939-939
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2894156089
- Cited by
- 156
- References
- 8
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients. https://app.cochat.ai/papers/10.3389/fphar.2018.00939
- The paper
- Šarenac, T. M., & Mikov, M. (2018). Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2018.00939
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.